Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep 3;7(9):e2435442.
doi: 10.1001/jamanetworkopen.2024.35442.

Tracking COVID-19 Infections Using Survey Data on Rapid At-Home Tests

Affiliations

Tracking COVID-19 Infections Using Survey Data on Rapid At-Home Tests

Mauricio Santillana et al. JAMA Netw Open. .

Abstract

Importance: Identifying and tracking new infections during an emerging pandemic is crucial to design and deploy interventions to protect populations and mitigate the pandemic's effects, yet it remains a challenging task.

Objective: To characterize the ability of nonprobability online surveys to longitudinally estimate the number of COVID-19 infections in the population both in the presence and absence of institutionalized testing.

Design, setting, and participants: Internet-based online nonprobability surveys were conducted among residents aged 18 years or older across 50 US states and the District of Columbia, using the PureSpectrum survey vendor, approximately every 6 weeks between June 1, 2020, and January 31, 2023, for a multiuniversity consortium-the COVID States Project. Surveys collected information on COVID-19 infections with representative state-level quotas applied to balance age, sex, race and ethnicity, and geographic distribution.

Main outcomes and measures: The main outcomes were (1) survey-weighted estimates of new monthly confirmed COVID-19 cases in the US from January 2020 to January 2023 and (2) estimates of uncounted test-confirmed cases from February 1, 2022, to January 1, 2023. These estimates were compared with institutionally reported COVID-19 infections collected by Johns Hopkins University and wastewater viral concentrations for SARS-CoV-2 from Biobot Analytics.

Results: The survey spanned 17 waves deployed from June 1, 2020, to January 31, 2023, with a total of 408 515 responses from 306 799 respondents (mean [SD] age, 42.8 [13.0] years; 202 416 women [66.0%]). Overall, 64 946 respondents (15.9%) self-reported a test-confirmed COVID-19 infection. National survey-weighted test-confirmed COVID-19 estimates were strongly correlated with institutionally reported COVID-19 infections (Pearson correlation, r = 0.96; P < .001) from April 2020 to January 2022 (50-state correlation mean [SD] value, r = 0.88 [0.07]). This was before the government-led mass distribution of at-home rapid tests. After January 2022, correlation was diminished and no longer statistically significant (r = 0.55; P = .08; 50-state correlation mean [SD] value, r = 0.48 [0.23]). In contrast, survey COVID-19 estimates correlated highly with SARS-CoV-2 viral concentrations in wastewater both before (r = 0.92; P < .001) and after (r = 0.89; P < .001) January 2022. Institutionally reported COVID-19 cases correlated (r = 0.79; P < .001) with wastewater viral concentrations before January 2022, but poorly (r = 0.31; P = .35) after, suggesting that both survey and wastewater estimates may have better captured test-confirmed COVID-19 infections after January 2022. Consistent correlation patterns were observed at the state level. Based on national-level survey estimates, approximately 54 million COVID-19 cases were likely unaccounted for in official records between January 2022 and January 2023.

Conclusions and relevance: This study suggests that nonprobability survey data can be used to estimate the temporal evolution of test-confirmed infections during an emerging disease outbreak. Self-reporting tools may enable government and health care officials to implement accessible and affordable at-home testing for efficient infection monitoring in the future.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Santillana reported receiving institutional research funds from the Johnson & Johnson Foundation, Janssen Global Public Health, and Pfizer Pharmaceuticals Inc. Drs Ognyanova and Baum reported receiving grants from the National Science Foundation during the conduct of the study. Dr Perlis reported receiving personal fees from Vault Health, Genomind, Circular Genomics, Psy Therapeutics, Swan AI Studios, and Belle outside the submitted work. No other disclosures were reported.

Figures

Figure.
Figure.. National Confirmed COVID-19 Infections, as Captured by Institutional and Survey Data, and Viral Concentrations of SARS-CoV-2 in Wastewater
The percentage of respondents in our survey who reported having a confirmed COVID-19 infection in each month is shown in orange (CSP), the institutionally reported percentage of individuals infected in each month as monitored by Johns Hopkins University (JHU) is shown in dark blue, and the wastewater viral concentration of SARS-CoV-2 is shown in light blue. A vertical dotted line shows the time when at-home rapid tests were widely available in February 2022. NYT indicates the New York Times.

Comment in

References

    1. Lipsitch M, Santillana M. Enhancing situational awareness to prevent infectious disease outbreaks from becoming catastrophic. Curr Top Microbiol Immunol. 2019;424:59-74. doi: 10.1007/82_2019_172 - DOI - PubMed
    1. Russell TW, Golding N, Hellewell J, et al. ; CMMID COVID-19 working group . Reconstructing the early global dynamics of under-ascertained COVID-19 cases and infections. BMC Med. 2020;18(1):332. doi: 10.1186/s12916-020-01790-9 - DOI - PMC - PubMed
    1. Brown TS, Walensky RP. Serosurveillance and the COVID-19 epidemic in the US: undetected, uncertain, and out of control. JAMA. 2020;324(8):749-751. doi: 10.1001/jama.2020.14017 - DOI - PubMed
    1. Centers for Disease Control and Prevention. COVID data tracker: COVID-19 update for the United States. Published November 20, 2023. Accessed November 21, 2023. https://covid.cdc.gov/covid-data-tracker/#datatracker-home
    1. Lu FS, Nguyen AT, Link NB, et al. Estimating the cumulative incidence of COVID-19 in the United States using influenza surveillance, virologic testing, and mortality data: four complementary approaches. PLoS Comput Biol. 2021;17(6):e1008994. doi: 10.1371/journal.pcbi.1008994 - DOI - PMC - PubMed

Publication types